Company Valuation: Theraclion

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 30.8 29.81 26.15 17.18 15.24 28.28
Change - -3.22% -12.29% -34.28% -11.33% 85.64%
Enterprise Value (EV) 1 39.07 36.8 32.67 17.6 18.65 36.14
Change - -5.81% -11.22% -46.11% 5.92% 93.8%
P/E -8.37x -7.93x -5.35x -5.1x -2.66x -6.33x
PBR -10.1x -23.4x 48.7x 3.14x -165,500x -13.9x
PEG - 0.3x -2.34x 0.1x -0x 0.3x
Capitalization / Revenue 41.4x 20.1x 21.2x 9.43x 18.4x 43.4x
EV / Revenue 52.5x 24.8x 26.4x 9.66x 22.5x 55.4x
EV / EBITDA -9.42x -8.35x -5.3x -5.83x -2.87x -4.92x
EV / EBIT -9.11x -8.11x -5.18x -5.58x -2.73x -4.67x
EV / FCF -12.2x -13.7x -6.8x -4.95x -76.9x -5.75x
FCF Yield -8.17% -7.31% -14.7% -20.2% -1.3% -17.4%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.2414 -0.1652 -0.1689 -0.0761 -0.1244 -0.0951
Distribution rate - - - - - -
Net sales 1 0.744 1.481 1.235 1.822 0.8302 0.652
EBITDA 1 -4.15 -4.405 -6.163 -3.021 -6.498 -7.347
EBIT 1 -4.288 -4.535 -6.307 -3.153 -6.819 -7.746
Net income 1 -3.905 -3.76 -4.964 -3.675 -5.757 -5.69
Net Debt 1 8.266 6.988 6.523 0.4215 3.411 7.852
Reference price 2 2.0200 1.3100 0.9040 0.3880 0.3310 0.6020
Nbr of stocks (in thousands) 15,249 22,757 28,925 44,287 46,031 46,985
Announcement Date 4/29/22 4/29/22 4/29/23 4/25/24 5/5/25 4/17/26
1EUR in Million2EUR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
23.5x4.3x16.57x0.4% 174B
44.28x11.59x25.94x-.--% 143B
28.54x - - 0.8% 127B
16.74x3.47x11.19x-.--% 67.78B
31x6.9x21.95x-.--% 50.07B
18.19x2.1x10.77x2.9% 43.84B
24.61x4.91x16.91x0.81% 35.78B
43.29x6.1x18.76x-.--% 35.07B
14.21x1.6x8.95x0.24% 28.99B
Average 27.15x 5.12x 16.38x 0.57% 78.38B
Weighted average by Cap. 28.82x 6.07x 18.05x 0.47%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!